IP Library Granted Patent US 8,173,176
Granted Patent B2
US 8,173,176 · App. 10/814,079 · Granted May 8, 2012

Embolization

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,173,176
App. No.
10/814,079
Granted
May 8, 2012
Kind
B2
Abstract

Embolization, as well as related particles, compositions and methods, are disclosed.

Claims (24)

1. A composition, comprising:

a plurality of substantially spherical porous silica particles, at least some of the plurality of substantially spherical silica particles having a diameter of from about 100 microns to about 3000 microns; and

a carrier fluid, the plurality of substantially spherical porous particles being in the carrier fluid,

wherein:

for at least some of the plurality of substantially spherical porous silica particles, a pore volume of the substantially spherical porous silica particles is from about 0.4 ml/g to about 1.6 ml/g; and

the plurality of substantially spherical porous silica particles have a pore volume distribution such that about 70% or more of the pore volume of the plurality of substantially spherical porous silica particles is made up of pores having pore diameters which have a tolerance of about 10 nm or less on the mean pore diameter.

2. The composition of claim 1 , wherein the carrier fluid comprises a saline solution.

3. The composition of claim 1 , wherein the carrier fluid comprises a contrast agent.

4. The composition of claim 1 , wherein at least some of the plurality of substantially spherical porous silica particles have a diameter of at most about 1500 microns.

5. The composition of claim 1 , wherein, for at least some of the plurality of substantially spherical porous silica particles, pores in the substantially spherical porous silica particles have a diameter of from about 20 nanometers to about 90 nanometers.

6. The composition of claim 1 , wherein, for at least some of the plurality of substantially spherical porous silica particles, the density of the particles is from about 1.1 grams per cubic centimeter to about 1.4 grams per cubic centimeter.

7. The composition of claim 1 , wherein the substantially spherical porous silica particles exhibit a loss of attrition resistance of about 0.1% by weight or less.

8. The composition of claim 1 , wherein at least some of the plurality of substantially spherical porous silica particles include a material selected from the group consisting of therapeutic agents, ferromagnetic materials, MRI visible materials and radiopaque materials.

9. The composition of claim 1 , wherein the plurality of substantially spherical porous silica particles are sterilized.

10. A composition, comprising:

a plurality of substantially spherical porous silica particles, at least some of the plurality of substantially spherical silica particles having a diameter of from about 100 microns to about 3000 microns; and

a carrier fluid, the plurality of substantially spherical porous particles being in the carrier fluid,

wherein, for at least some of the plurality of substantially spherical porous silica particles, the density of the particles is from about 1.1 grams per cubic centimeter to about 1.4 grams per cubic centimeter, and the carrier fluid comprises a saline solution, wherein the plurality of substantially spherical porous silica particles have a pore volume distribution such that about 70% or more of the pore volume of the plurality of substantially spherical porous silica particles is made up of pores having pore diameters which have a tolerance of about 10 nm or less on the mean pore diameter.

11. The composition of claim 10 , wherein the substantially spherical porous silica particles exhibit a loss of attrition resistance of about 0.1% by weight or less.

12. A composition, comprising:

a plurality of substantially spherical porous silica particles, at least some of the plurality of substantially spherical silica particles having a diameter of from about 100 microns to about 3000 microns; and

a carrier fluid, the plurality of substantially spherical porous particles being in the carrier fluid,

wherein the plurality of substantially spherical porous silica particles have a pore volume distribution such that about 70% or more of the pore volume of the plurality of substantially spherical porous silica particles is made up of pores having pore diameters which have a tolerance of about 10 nm or less on the mean pore diameter.

13. The composition of claim 12 , wherein the substantially spherical porous silica particles exhibit a loss of attrition resistance of about 0.1% by weight or less.

Assignments (1)
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →